TPL Opening Disclosure Statement 12-23-13 found in BaNosser post as follows:

http://agoracom.com/ir/patriot/forums/discussion/topics/596380-tpl-bk-documents-dec-16-17-23/messages/1870873#message

p.87 TPL’s forecast assumes half of the remaining MMP revenue comes from litigants, while half is from non-litigants. Because of the different contingency percentage related to litigants versus non-litigants, TPL’s forecast predicts approximately twice the amount of revenue coming from PDS to TPL will be from non-litigants…………………………………If PDS is dissolved, then TPL and Patriot Scientific would each have the right to license the portfolio unless a different agreement were reached, and that could negatively impact TPL’s revenues from the MMP Portfolio. In addition, there has been a history of litigation between Patriot and TPL, and if that begins again, it may negatively impact the portfolio revenues. Another material assumption TPL made with respect to MMP revenue is that Alliacense will continue to provide program management services to PDS under the terms of the existing services agreement between PDS and Alliacense. If Alliacense stops providing the services currently provided, or required a significant change in the terms of the existing agreement, TPL’s MMP revenues could be significantly affected